Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

40 results about "Human cartilage" patented technology

Hyaline cartilage, Fibrocartilage and Elastic cartilage are the three major types of cartilage in the human body. A cartilage is made up of extracellular matrix composed of collagen fibers, ground substance that is rich in proteoglycan, and elastin fibers. The three types of cartilage, described above,...

Preparation method of high-strength double-network nano hectorite composite aquagel

The invention discloses a preparation method of a high-strength double-network nano hectorite composite aquagel. The method comprises the following steps: preparing a nano hectorite water solution with cooled boiled distilled water, and dissolving sodium alginate, acrylamide, a crosslinking agent, an initiator and a catalyst in the hectorite water solution, quickly transferring the prepared solution into a glass mold, putting the sealed mold in a 45-55 DEG C environment, and keeping the temperature to react for 2-6 hours; and taking out the formed aquagel in the mold, immersing in a 0.1-1M CaCl2 water solution for 2-6 hours, and taking out to obtain the high-strength double-network nano hectorite composite aquagel. Compared with the traditional aquagel, the composite aquagel has higher strength and percentage of elongation, thereby satisfying the application demands for human cartilage restoration, tissue engineering and other aspects.
Owner:QILU UNIV OF TECH

Trimeric costimulatory TNF family ligand-containing antigen binding molecules

The invention relates to novel trimeric costimulatory TNF family ligand-containing antigen binding molecules comprising three fusion polypeptides, each of the three fusion polypeptides comprising (a) an ectodomain of a costimulatory TNF family ligand selected from the group consisting of 4-1BBL, OX40L and GITRL or fragments thereof, (b) a trimerization domain, in particular a trimerization domain derived from human cartilage matrix protein (huCMP) of SEQ ID NO:1, and (c) a moiety capable of specific binding to a target cell antigen, and to methods of producing these molecules and to methods of using the same.
Owner:F HOFFMANN LA ROCHE & CO AG

Preparation method of novel high-strength micro-gel composite hydrogel

The invention discloses a preparation method of a novel high-strength micro-gel composite hydrogel. According to the invention, acrylamide and 2-acrylamide-dimethylpropane sulfonic acid are adopted as main monomers; N-methylol acrylamide is adopted as a functional monomer; reactive micro-gel containing hydroxymethyl is obtained through inverse emulsion polymerization; the micro-gel particles are dispersed into the water solution of acrylamide and 2-acrylamide-dimethylpropane sulfonic acid, and free radical polymerization is carried out, such that a micro-gel composite polymer is obtained; and the micro-gel composite polymer or a partially dehydrated micro-gel composite polymer is heated and is subjected to cross-linking, such that the micro-gel composite hydrogel is obtained. According to the invention, nano-clay is adopted as the cross-linking agent. The prepared composite hydrogel has higher mechanical strength, and high water absorption rate. The strength and water content of the hydrogel are similar to those of human cartilage tissues. Therefore, the hydrogel is an alternative material for cartilage tissue reparation.
Owner:临沂市高新汽车租赁服务有限公司

Oligomeric receptor ligand pair member complexes

This invention concerns an oligomeric receptor-ligand pair member complex which includes (i) an oligomeric core, said core comprising at least two chimeric proteins, said chimeric proteins comprising a first section including at least one domain forming part of a first member of a complementary binding pairand a second section comprising an oligomerising domain derived from an oligomer-forming coiled-coil protein, wherein formation of the oligomeric core occurs by oligomerisation at the oligomerising domain of the chimeric proteins; and (ii) at least two receptor-ligand pair member peptides derived from a receptor-ligand pair member peptide chain or a functional part thereof, wherein each receptor-ligand pair member peptide further comprises attached thereto a second member of said complementary binding pair capable of binding to the first complementary binding pair member as defined in (i). Each receptor-ligand pair member peptide is bound to the core via binding of the first and second members of the complementary binding pair. At least two of the receptor-ligand pair member peptides in the complex are derived from the same receptor-ligand pair member peptide chain. In one embodiment, the oligomerising domain in the second section in at least one of the chimeric proteins is derived from the pentamerisation domain of the human cartilage oligomeric matrix protein (COMP). The invention further concerns related pharmaceutical and diagnostic compositions and processes.
Owner:PROIMMUNE

Preparation method of immortalized human cartilage endplate stem cell line and use of immortalized human cartilage endplate stem cell line

InactiveCN103865877AStrong osteogenic differentiation abilityLow priceMicroorganism based processesFermentationBone tissue engineeringStem cell line
The invention belongs to the technical field of cell engineering, and particularly relates to a preparation method of an immortalized human cartilage endplate stem cell line and use of the immortalized human cartilage endplate stem cell line. The invention aims to solve the technical problem of providing an effective preparation method for constructing the immortalized human cartilage endplate stem cell line. The technical scheme is as follows: the preparation method for constructing the immortalized human cartilage endplate stem cell line by adopting the lentiviral transfection technology comprises the following steps: a, constructing a SV40T antigen virus vector; b, carrying out gene transfection of a human endplate stem cell on SV40T antigen; and c, passaging and sieving to obtain the immortalized human cartilage endplate stem cell line. The invention further provides the use of the immortalized human cartilage endplate stem cell line prepared by the method in preparation of bone tissue engineering materials. The immortalized human cartilage endplate stem cell line provided by the invention can be applied to preparation of a tissue-engineered bone and clinically provides a seed cell of the bone tissue engineering low in price and strong in osteogenic capability for the patients with a series of long bone defects and bone nonunion.
Owner:THE SECOND AFFILIATED HOSPITAL ARMY MEDICAL UNIV

Induction method for promoting differentiation of human umbilical cord mesenchymal stem cells into chondrocytes

InactiveCN109825469ANo effect on proliferative abilityNo effect on differentiation abilityDead animal preservationSkeletal/connective tissue cellsEvery Three DaysUmbilical cord tissue
The invention relates to an induction method for promoting differentiation of human umbilical cord mesenchymal stem cells into chondrocytes, which comprises the following steps of: obtaining an umbilical cord tissue block, a primary culturing stem cells, subculturingstem cells and inducing stem cells differentiate to chondrocytes, wherein the induction for differentiation of stem cellsinto chondrocytes comprises the following steps of: resuspending human umbilical cord mesenchymal stem cells subcultured to a seventh generation by adopting a serum-free culture medium to prepare P7 generation stem cell suspension; inoculating P7 generation stem cell suspension into the serum-free culture medium containing a cartilage differentiation inducer for continuous culture; replacing the serum-free culture medium containing the cartilage differentiation inducer in a half amount every three days; obtaining chondrocytes after 14 days.The induction method can differentiate human umbilical cord mesenchymal stem cells into chondrocytes,which has important significance in repairing human cartilage tissues and treating bone injuries.
Owner:和携科技有限公司

High-strength degradable cartilage tissue engineering scaffold and preparation method thereof

The invention discloses a high-strength degradable cartilage tissue engineering scaffold and a preparation method thereof. The high-strength degradable cartilage tissue engineering scaffold is formed by compounding chitosan and gelatine in weight ratio of 1:(0.01-2), wherein mass percent concentration of chitosan is 3-6%, and mass percent concentration of gelatine is 0.03-10%. The preparation method of the high-strength degradable cartilage tissue engineering scaffold is characterized in that natural biological materials such as chitosan and gelatine are adopted as raw materials, an in-situ precipitation and freeze-drying method is adopted for preparing a chitosan-gelatin compound porous scaffold which has excellent mechanical performance, controllable degradation rate and excellent biocompatibility, is not added with a crosslinking agent and is composed of pure natural biological materials. The chitosan-gelatin compound porous scaffold has the advantages that a degradation period can be regulated according to proportional relation between gelatine and chitosan, and growth rate matching probability of regenerated tissues is improved; and experiments verify that human cartilage cells can be well adhered and propagated on the surface of the materials.
Owner:NINGBO MEDICAL CENT LIHUILI HOSPITACL

Healthy food and drug composition for improving cartilage metabolic disorder diseases

The invention discloses healthy food and drug composition for improving cartilage metabolic disorder diseases, and relates to the technical field of drugs. The healthy food and drug composition is prepared from the following components: polypeptide glucosamine chondroitin, calcium L-threonate, ethanol extract and glucosamine sulfate, wherein main components of the polypeptide glucosamine chondroitin comprise glucosamine sulfate, chondroitin sulfate, soybean peptide powder, radix puerariae powder, calcium carbonate, microcrystalline cellulose and magnesium stearate, and glucosamine sulfate is prepared from chitin as a raw material. The healthy food and drug composition for improving the cartilage metabolic disorder diseases not only can realize the effects of common inflammation diminishingand pain relieving and has no side effects, but also can further improve drug absorption by human cartilage on the basis of human immunity improvement, so that the problem of low drug absorption ratecaused by cartilage metabolic disorder can be solved to a certain extent, and a good physiotherapy effect on the human cartilage can be realized.
Owner:ZIBO VOCATIONAL INST

Method for measuring human cartilage endochrome and application of human cartilage endochrome in forensic medicine

The invention belongs to the technical field of forensic humans, and particularly relates to a method for determining human cartilage endochrome and application of the human cartilage endochrome in forensic medicine. An in-vitro cartilage section image is obtained by using a scanner, and image processing software is used for obtaining a pigmentation quantification method of an average gray value of an image. A linear model based on human cartilage endochrome quantification and age correlation is established. The method disclosed by the invention is simple and convenient to operate, low in costand high in accuracy, has very high forensic value, and can be popularized in forensic practice.
Owner:SHANGHAI CRIMINAL SCI TECH RES INST +1

Application of YKL-40 as glioblastoma biomarker

The invention relates to application of human cartilage glycoprotein (YKL-40) as a glioblastoma biomarker. The glioblastoma (Glioblastoma, GBM) patient is low in survival rate and poor in prognosis. Effective biomarker and monitoring method are absent at present. The invention finds that the overall YKL-40 meso-position expression is obviously increased (Fold change=9.483, P<0.0001) by analyzing the YKL-40 mRNA gene expression data of the glioblastoma patient in a TCGA (The Cancer Genome Atlas) database. 45 IV-stage Chinese people glycoprotein clinic samples are further collected, and after qPCR process is adopted for quantitatively analyzing the YKL-40 expression and the prognosis correlation analysis is performed, the YKL-40 mRNA transcriptional level of 41 patients is obviously increased and the patients are short in lifetime and poor in prognosis. The invention analyzes and verifies that the YKL-40 is closely related to the lifetime and poor prognosis, the YKL-40 can be used as a potential glioblastoma biomarker, and a qPCR or protein quantitative monitoring method can be utilized to indicate the lifetime and prognosis of the glioblastoma patient.
Owner:BEIJING TRICISIONBIO THERAPEUTICS INC

Cartilage progenitor cell culture medium and preparation method and application thereof

The invention provides a cartilage progenitor cell culture medium which is composed of DMEM culture medium, F12 culture medium, proline, sodium pyruvate, vitamin C, insulin growth factor, FGF2, transferrin, ROCK inhibitor, p38 inhibitor and GSK-3 alpha / beta inhibitor. The preparation method comprises the following steps: mixing the components, adjusting the pH and osmotic pressure of an obtained mixture, and sterilizing. According to the invention, enough nutrient substances and a stable living environment are provided for culturing cells, so that the cells have excellent self-renewal capability. As no animal-derived component is used, pollution caused by animal-derived components is effectively avoided, and immune response is completely prevented from being induced. The preparation methodof the culture medium has the advantages that steps are simple, raw materials are easily available, and no serum is contained, the undifferentiated and pluripotent state of CPCs can be maintained, and the cartilage progenitor cell culture medium is specially used for culturing and amplifying cartilage progenitor cells. The invention disclsoes a long-lasting, continuous and efficient CPCs culturesystem, so that in vitro stable propagation of functional mice and human cartilage progenitor cells is possible to realize.
Owner:ZHEJIANG UNIV

Human cartilage glycoprotein

Nucleic acid sequences for HC gp-39L are provided. Methods of detecting altered expression of tissue remodeling proteins and diagnosing tissue remodeling disorders are also provided.
Owner:SMITHKLINE BECKMAN CORP

Multi-joint detection kit for rapidly detecting liver diseases and preparation method thereof

ActiveCN110687288AEarly detection is fast and accurateEasy to operateMaterial analysisFetuin bOsteopontin
The invention discloses a multi-joint detection kit for rapidly detecting liver diseases and a preparation method thereof. The multi-joint detection kit adopts a fluorescence immunochromatographic method; four fluorescence detection cards are prepared from four markers, including angiopoietin-like protein 2 (angptl2), alpha fetoprotein (AFP), serum osteopontin (OPN) and human cartilage glycoprotein (YKL-40), which are used for detecting liver diseases; the four detection cards are arranged and connected together in parallel to form a kit body; every two adjacent detection cards have a sample adding hole; and each detection card is provided with a card reading window. The multi-joint detection kit can detect four different markers of liver diseases at the same time, can comprehensively monitor liver cirrhosis, liver cancer and liver cancer prognosis, and enables early detection of liver diseases to be faster and more precise; and the operation is simple, the detection time is short, four detection results can be obtained only by adding samples twice, and the results can be obtained within 10 minutes after sample adding is completed, so that the multi-joint detection kit is more suitable for primary level application.
Owner:SUN YAT SEN UNIV CANCER CENT +1

In-vitro construction method of epiphyseal plate cartilage

InactiveCN106075580ASolve source difficultiesAvoid the problem of easy differentiation into fibroblastsTissue regenerationProsthesisCylindromaTrypsinization
The invention relates to the technical field of tissue engineering, and in particular relates to an in-vitro construction method of epiphyseal plate cartilage. The in-vitro construction method of the epiphyseal plate cartilage comprises the following steps: (1) culturing human cartilage cell line cells or human bone marrow stem cells till cell monolayers are formed, carrying out trypsinization, washing and resuspension to obtain a cell suspension, and carrying out counting for later use; (2) cutting a pretreated bone matrix gelatin material into a cylinder with the diameter smaller than the diameter of each culture hole, drilling a pore passage running through the two bottom surfaces of the cylinder in the cylinder, carrying out sterilization treatment, and fixing the cut bone matrix gelatin material in the culture holes in a suspension manner; and (3) implanting the cell suspension obtained in the step (1) to be below the bone matrix gelatin material from the pore passage, enabling the liquid level to wet the bone matrix gelatin material, and carrying out culturing to obtain the epiphyseal plate cartilage. With the adoption of the technical scheme, a culture system of C28 / I2 cells and an in-vitro construction method of the epiphyseal plate cartilage by adopting the culture system are established, and therefore, the problem that the seed cells are difficultly available is solved; the cells are stable in character and low in culturing cost.
Owner:XI AN JIAOTONG UNIV

Preparation method and application of immortalized human cartilage endplate stem cell line

InactiveCN103865877BStrong osteogenic differentiation abilityLow priceMicroorganism based processesGenetic engineeringAntigenStem cell line
The invention belongs to the technical field of cell engineering, and particularly relates to a preparation method of an immortalized human cartilage endplate stem cell line and use of the immortalized human cartilage endplate stem cell line. The invention aims to solve the technical problem of providing an effective preparation method for constructing the immortalized human cartilage endplate stem cell line. The technical scheme is as follows: the preparation method for constructing the immortalized human cartilage endplate stem cell line by adopting the lentiviral transfection technology comprises the following steps: a, constructing a SV40T antigen virus vector; b, carrying out gene transfection of a human endplate stem cell on SV40T antigen; and c, passaging and sieving to obtain the immortalized human cartilage endplate stem cell line. The invention further provides the use of the immortalized human cartilage endplate stem cell line prepared by the method in preparation of bone tissue engineering materials. The immortalized human cartilage endplate stem cell line provided by the invention can be applied to preparation of a tissue-engineered bone and clinically provides a seed cell of the bone tissue engineering low in price and strong in osteogenic capability for the patients with a series of long bone defects and bone nonunion.
Owner:THE SECOND AFFILIATED HOSPITAL ARMY MEDICAL UNIV

Peptide for differentiating osteoarthritis from rheumatoid arthritis and non-disease conditions

A method for differentiation of osteoarthritis from rheumatoid arthritis and non-disease conditions in a sample, comprising measuring in the sample the concentration of a peptide comprising the 15 amino acid sequence (SEQ ID NO: 1) of the human cartilage intermediate layer protein 2.
Owner:LORENZO PILAR +2

Preparation method for stem cell extract-rich degradable biofilm for wound repair

The invention discloses a preparation method for a stem cell extract-rich degradable biofilm for wound repair. The preparation method comprises the following steps: adding extracted bone marrow into a mesenchymal stem cell culture solution, discarding supernatant after centrifugation, then performing inoculation in a culture dish at 1*109 / mL, performing culturing in an incubator, and inoculating third-generation mesenchymal stem cells into a fiberboard laid with a fibrin film to prepare a mesenchymal stem cell-fibrin film. According to the preparation method, mesenchymal stem cells are separated and cultured, the fibrin film is used as a stent material, and the in-vitro cultured mesenchymal stem cells and the fibrin film are combined and transplanted to a cartilage damaged part to achieve the effect of repairing a damaged cartilage. The mesenchymal stem cells can be better limited by the fibrin film to be grown and reproduced on the surface of a cartilage damaged wound so as to play an important role in a cartilage wound repair process more effectively and play a certain guiding role in human cartilage damage repair.
Owner:ANHUI HUIEN BIOTECH

Method for serum-free culture of chondrocytes and serum-free culture medium

To provide a method for serum-free culture of human cartilage cells and a serum-free culture medium. A method for serum-free culture of cartilage cells, said method comprising: an enzymatic treatment step for treating a human cartilage cell-containing tissue with a protease; an inhibitor-treatment step for, after the enzymatic treatment step, treating the tissue with an inhibitor for the aforesaid protease; and a culture step for, after the inhibitor-treatment step, culturing the tissue in a serum-free culture medium that contains kartogenin and / or SAG, ITS, FGF2 and hydrocortisone. A serum-free culture medium for culturing cartilage cells, said serum-free culture medium containing kartogenin and / or SAG, ITS, FGF2 and hydrocortisone.
Owner:REGENESIS SCI CO LTD

A method for constructing epiphyseal plate cartilage in vitro

InactiveCN106075580BSolve source difficultiesAvoid the problem of easy differentiation into fibroblastsSkeletal/connective tissue cellsTissue regenerationCylindromaTrypsinization
The invention relates to the technical field of tissue engineering, and in particular relates to an in-vitro construction method of epiphyseal plate cartilage. The in-vitro construction method of the epiphyseal plate cartilage comprises the following steps: (1) culturing human cartilage cell line cells or human bone marrow stem cells till cell monolayers are formed, carrying out trypsinization, washing and resuspension to obtain a cell suspension, and carrying out counting for later use; (2) cutting a pretreated bone matrix gelatin material into a cylinder with the diameter smaller than the diameter of each culture hole, drilling a pore passage running through the two bottom surfaces of the cylinder in the cylinder, carrying out sterilization treatment, and fixing the cut bone matrix gelatin material in the culture holes in a suspension manner; and (3) implanting the cell suspension obtained in the step (1) to be below the bone matrix gelatin material from the pore passage, enabling the liquid level to wet the bone matrix gelatin material, and carrying out culturing to obtain the epiphyseal plate cartilage. With the adoption of the technical scheme, a culture system of C28 / I2 cells and an in-vitro construction method of the epiphyseal plate cartilage by adopting the culture system are established, and therefore, the problem that the seed cells are difficultly available is solved; the cells are stable in character and low in culturing cost.
Owner:XI AN JIAOTONG UNIV

Cartilage tissue repair membrane and preparation method thereof

InactiveCN105233337AMeet the repair requirementsEasy to prepareProsthesisCelluloseSkeletal tissue
The invention discloses a cartilage tissue repair membrane and a preparation method thereof. The cartilage tissue repair membrane is mainly made from, by weight: 25-50 parts of collagen, 13-28 parts of glycosaminoglycans, 11-24 parts of hyaluronic acid, 8-24 parts of chitosan, 4-14 parts of fibronectin, 10-32 parts of keratin, 5-15 parts of membrane fiber, 14-26 parts of sorbitol, 10-25 parts of sodium lauryl sulfate, 14-36 parts of cellulose gum, 10-26 parts of benzyl alcohol, and 35-65 parts of double distilled water. Compared with the prior art, the invention has the advantages that the prepared cartilage tissue repair membrane has water content 60-80% and meets the requirement for repairing human cartilage tissues; the preparation method of the cartilage tissue repair membrane is simple, quick and low in cost.
Owner:SUZHOU COSMETIC MATERIALS

Earphone

InactiveCN104602145AReduce oppressionWill not affect the sound collection functionEarpiece/earphone attachmentsUltrasound attenuationExternal Auditory Canals
The present invention provides an earphone and solves technical problems of large volume and large external audio attenuation of a conventional earphone receiver. The earphone includes a hollow V-shaped fixing rack. The bottom of the V-shaped fixing rack is fixedly connected with a hollow fixing housing. The internal space of the V-shaped fixing rack is communicated with that of the fixing housing. A Sound hole is arranged on the V-shaped fixing rack and / or the fixing housing. The earphone of the present invention has a small volume. The sound hole is lower than a tragus and an antitragus. Thus, an external auditory canal cannot be blocked and a sound collecting function of a human ear cannot be affected. The small volume cannot cause foreign body sensation and has low pressure on a human cartilage, thereby achieving a high wearing comfort level. The thickness of the hollow fixing housing equals the width of an intertragic incisura of the human ear such that the security of earphone is higher than that of the conventional earphone. The earphone of the present invention has a good fixing effect and the supporting capacity of the receiver reaches about 0.6Kg such that the receiver is not liable to fall from the ears.
Owner:XIAN BLUE DIAMOND ELECTRONICS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products